Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19

NCT04359212 · clinicaltrials.gov ↗

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Disease
Thromboembolism, Venous

Interventions

DRUG: thromboprophylaxis with low-molecular-weight heparin or fondaparinux

Sponsor

Quovadis Associazione

Collaborators

[object Object]